Necitumumab is a human IgG monoclonal antibody directed against EGFR. Necitumumab can be used for research of NSCLC, colorectal cancer, etc.
References:
[1]. Garnock-Jones KP. Necitumumab: First Global Approval. Drugs. 2016 Feb;76(2):283-9.
Necitumumab是一种针对EGFR的人IgG单克隆抗体。
| 规格 | 价格 | 库存 | 数量 | 操作 |
|---|---|---|---|---|
| 1 mg | ¥1,080.00 | 现货 | 1 | |
| 5 mg | ¥3,150.00 | 现货 | 1 | |
| 10 mg | ¥5,400.00 | 现货 | 1 |
















Necitumumab is a human IgG monoclonal antibody directed against EGFR. Necitumumab can be used for research of NSCLC, colorectal cancer, etc.
References:
[1]. Garnock-Jones KP. Necitumumab: First Global Approval. Drugs. 2016 Feb;76(2):283-9.